APO Research
Talk to an analyst

APO RESEARCH · REPORT

6-FDA

4,4'-(Hexafluoroisopropylidene) diphthalic anhydride (also named as 6FDA, CAS 1107-00-2) is typically used as monomer in the preparation of fluorinated colorless polyimide films (CPI) and polyimide composites.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

4,4'-(Hexafluoroisopropylidene) diphthalic anhydride (also named as 6FDA, CAS 1107-00-2) is typically used as monomer in the preparation of fluorinated colorless polyimide films (CPI) and polyimide composites.

Selected research

Market Outlook & Growth Opportunities

Global 6-FDA Market Outlook and Growth Opportunities 2026

1 January 2026191 pages

Choose your research edition.

Industry Research6-FDA Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal 6-FDA Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal 6-FDA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 6-FDA Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal 6-FDA Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

4,4'-(Hexafluoroisopropylidene) diphthalic anhydride (also named as 6FDA, CAS 1107-00-2) is typically used as monomer in the preparation of fluorinated colorless polyimide films (CPI) and polyimide composites.

Currently, Daikin, Chemours, Chinatech Chemical and Zigong Zhongtiansheng New Material are major manufacturers of this industry. Daikin is a global leader. In 2019, the company held a share of about 63%.

Japan is the largest consumption area of 6-FDA, which accounted for over 44% market share in 2019. Following Japan, Korea and USA took up market share of about 21% and 18%, which is in the second and third places.

Read the full market overview

This report provides an overview of the global 6-FDA market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 6-FDA and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 6-FDA sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 6-FDA market size, projected growth trends, production technologies, key applications, and end-use industries.

6-FDA Segment by Company

Daikin

Chemours

Chinatech Chemical

Zigong Zhongtiansheng New Material

Zhejiang Nuocheng

6-FDA Segment by Purity

99% Purity 6-FDA

99.5% Purity 6-FDA

6-FDA Segment by Application

Polyimide Film

Fluorinated Polyimide

6-FDA Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global 6-FDA status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions 6-FDA market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify 6-FDA significant trends, drivers, influence factors in global and regions.

6. To analyze 6-FDA competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 6-FDA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 6-FDA and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 6-FDA.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 6-FDA market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 6-FDA industry.

Chapter 3: Detailed analysis of 6-FDA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of 6-FDA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of 6-FDA in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. 6-FDA Industry Trends Table 2. 6-FDA Industry Drivers Table 3. 6-FDA Industry Opportunities and Challenges Table 4. 6-FDA Industry Restraints Table 5. Global 6-FDA Revenue by Company (US$ Million) & (2021-2026) Table 6. Global 6-FDA Revenue Share by Company (2021-2026) Table 7. Global 6-FDA Sales Volume by Company (MT) & (2021-2026) Table 8. Global 6-FDA Sales Volume Share by Company (2021-2026) Table 9. Global 6-FDA Average Price (USD/Kg) of Company (2021-2026) Table 10. Global 6-FDA Company Ranking, (2024-2026) & (USD Million) Table 11. Global 6-FDA Key Company Manufacturing Base & Headquarters Table 12. Global 6-FDA Company, Product Type & Application Table 13. Global 6-FDA Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global 6-FDA by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 99% Purity 6-FDA Table 18. Significant Companies of 99.5% Purity 6-FDA Table 19. Global 6-FDA Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 20. Global 6-FDA Sales Volume by Type (2021-2026) & (MT) Table 21. Global 6-FDA Sales Volume by Type (2027-2032) & (MT) Table 22. Global 6-FDA Sales Volume Share by Type (2021-2026) Table 23. Global 6-FDA Sales Volume Share by Type (2027-2032) Table 24. Global 6-FDA Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global 6-FDA Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global 6-FDA Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global 6-FDA Sales Value Share by Type (2021-2026) Table 28. Global 6-FDA Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Polyimide Film Table 30. Significant Companies of Fluorinated Polyimide Table 31. Global 6-FDA Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 32. Global 6-FDA Sales Volume by Application (2021-2026) & (MT) Table 33. Global 6-FDA Sales Volume by Application (2027-2032) & (MT) Table 34. Global 6-FDA Sales Volume Share by Application (2021-2026) Table 35. Global 6-FDA Sales Volume Share by Application (2027-2032) Table 36. Global 6-FDA Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global 6-FDA Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global 6-FDA Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global 6-FDA Sales Value Share by Application (2021-2026) Table 40. Global 6-FDA Sales Value Share by Application (2027-2032) Table 41. Global 6-FDA Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 42. Global 6-FDA Sales by Region (2021-2026) & (MT) Table 43. Global 6-FDA Sales Market Share by Region (2021-2026) Table 44. Global 6-FDA Sales by Region (2027-2032) & (MT) Table 45. Global 6-FDA Sales Market Share by Region (2027-2032) Table 46. Global 6-FDA Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global 6-FDA Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global 6-FDA Sales Value Share by Region (2021-2026) Table 49. Global 6-FDA Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global 6-FDA Sales Value Share by Region (2027-2032) Table 51. Global 6-FDA Market Average Price (USD/Kg) by Region (2021-2026) Table 52. Global 6-FDA Market Average Price (USD/Kg) by Region (2027-2032) Table 53. Global 6-FDA Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 54. Global 6-FDA Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global 6-FDA Sales by Country (2021-2026) & (MT) Table 56. Global 6-FDA Sales Market Share by Country (2021-2026) Table 57. Global 6-FDA Sales by Country (2027-2032) & (MT) Table 58. Global 6-FDA Sales Market Share by Country (2027-2032) Table 59. Global 6-FDA Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global 6-FDA Sales Value Market Share by Country (2021-2026) Table 61. Global 6-FDA Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global 6-FDA Sales Value Market Share by Country (2027-2032) Table 63. Daikin Company Information Table 64. Daikin Business Overview Table 65. Daikin 6-FDA Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 66. Daikin 6-FDA Product Portfolio Table 67. Daikin Recent Development Table 68. Chemours Company Information Table 69. Chemours Business Overview Table 70. Chemours 6-FDA Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 71. Chemours 6-FDA Product Portfolio Table 72. Chemours Recent Development Table 73. Chinatech Chemical Company Information Table 74. Chinatech Chemical Business Overview Table 75. Chinatech Chemical 6-FDA Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 76. Chinatech Chemical 6-FDA Product Portfolio Table 77. Chinatech Chemical Recent Development Table 78. Zigong Zhongtiansheng New Material Company Information Table 79. Zigong Zhongtiansheng New Material Business Overview Table 80. Zigong Zhongtiansheng New Material 6-FDA Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 81. Zigong Zhongtiansheng New Material 6-FDA Product Portfolio Table 82. Zigong Zhongtiansheng New Material Recent Development Table 83. Zhejiang Nuocheng Company Information Table 84. Zhejiang Nuocheng Business Overview Table 85. Zhejiang Nuocheng 6-FDA Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 86. Zhejiang Nuocheng 6-FDA Product Portfolio Table 87. Zhejiang Nuocheng Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. 6-FDA Distributors List Table 91. 6-FDA Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. 6-FDA Product Image Figure 2. Global 6-FDA Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 6-FDA Sales Value (2021-2032) & (US$ Million) Figure 4. Global 6-FDA Sales (2021-2032) & (MT) Figure 5. Global 6-FDA Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global 6-FDA Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 99% Purity 6-FDA Image Figure 10. 99.5% Purity 6-FDA Image Figure 11. Global 6-FDA Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global 6-FDA Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global 6-FDA Sales Volume Share by Type (2021-2032) Figure 14. Global 6-FDA Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global 6-FDA Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global 6-FDA Sales Value Share by Type (2021-2032) Figure 17. Polyimide Film Image Figure 18. Fluorinated Polyimide Image Figure 19. Global 6-FDA Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 20. Global 6-FDA Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global 6-FDA Sales Volume Share by Application (2021-2032) Figure 22. Global 6-FDA Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global 6-FDA Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global 6-FDA Sales Value Share by Application (2021-2032) Figure 25. Global 6-FDA Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 26. Global 6-FDA Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global 6-FDA Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global 6-FDA Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America 6-FDA Sales Value (2021-2032) & (US$ Million) Figure 30. North America 6-FDA Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe 6-FDA Sales Value (2021-2032) & (US$ Million) Figure 32. Europe 6-FDA Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific 6-FDA Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific 6-FDA Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America 6-FDA Sales Value (2021-2032) & (US$ Million) Figure 36. South America 6-FDA Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa 6-FDA Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa 6-FDA Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt 6-FDA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt 6-FDA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt 6-FDA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. 6-FDA Value Chain Figure 124. Manufacturing Cost Structure Figure 125. 6-FDA Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 99% Purity 6-FDA
  • 99.5% Purity 6-FDA
Applications
  • Polyimide Film
  • Fluorinated Polyimide
Companies covered
  • Daikin
  • Chemours
  • Chinatech Chemical
  • Zigong Zhongtiansheng New Material
  • Zhejiang Nuocheng

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 6-FDA Sales Value (2021-2032)
  4. 1.2.2 Global 6-FDA Sales Volume (2021-2032)
  5. 1.2.3 Global 6-FDA Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 6-FDA Market Dynamics
  1. 2.1 6-FDA Industry Trends
  2. 2.2 6-FDA Industry Drivers
  3. 2.3 6-FDA Industry Opportunities and Challenges
  4. 2.4 6-FDA Industry Restraints
3 6-FDA Market by Company
  1. 3.1 Global 6-FDA Company Revenue Ranking in 2025
  2. 3.2 Global 6-FDA Revenue by Company (2021-2026)
  3. 3.3 Global 6-FDA Sales Volume by Company (2021-2026)
  4. 3.4 Global 6-FDA Average Price by Company (2021-2026)
  5. 3.5 Global 6-FDA Company Ranking (2024-2026)
  6. 3.6 Global 6-FDA Company Manufacturing Base and Headquarters
  7. 3.7 Global 6-FDA Company Product Type and Application
  8. 3.8 Global 6-FDA Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global 6-FDA Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 6-FDA Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 6-FDA Market by Type
  1. 4.1 6-FDA Type Introduction
  2. 4.1.1 99% Purity 6-FDA
  3. 4.1.2 99.5% Purity 6-FDA
  4. 4.2 Global 6-FDA Sales Volume by Type
  5. 4.2.1 Global 6-FDA Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global 6-FDA Sales Volume by Type (2021-2032)
  7. 4.2.3 Global 6-FDA Sales Volume Share by Type (2021-2032)
  8. 4.3 Global 6-FDA Sales Value by Type
  9. 4.3.1 Global 6-FDA Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global 6-FDA Sales Value by Type (2021-2032)
  11. 4.3.3 Global 6-FDA Sales Value Share by Type (2021-2032)
5 6-FDA Market by Application
  1. 5.1 6-FDA Application Introduction
  2. 5.1.1 Polyimide Film
  3. 5.1.2 Fluorinated Polyimide
  4. 5.2 Global 6-FDA Sales Volume by Application
  5. 5.2.1 Global 6-FDA Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global 6-FDA Sales Volume by Application (2021-2032)
  7. 5.2.3 Global 6-FDA Sales Volume Share by Application (2021-2032)
  8. 5.3 Global 6-FDA Sales Value by Application
  9. 5.3.1 Global 6-FDA Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global 6-FDA Sales Value by Application (2021-2032)
  11. 5.3.3 Global 6-FDA Sales Value Share by Application (2021-2032)
6 6-FDA Regional Sales and Value Analysis
  1. 6.1 Global 6-FDA Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 6-FDA Sales by Region (2021-2032)
  3. 6.2.1 Global 6-FDA Sales by Region: 2021-2026
  4. 6.2.2 Global 6-FDA Sales by Region (2027-2032)
  5. 6.3 Global 6-FDA Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global 6-FDA Sales Value by Region (2021-2032)
  7. 6.4.1 Global 6-FDA Sales Value by Region: 2021-2026
  8. 6.4.2 Global 6-FDA Sales Value by Region (2027-2032)
  9. 6.5 Global 6-FDA Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America 6-FDA Sales Value (2021-2032)
  12. 6.6.2 North America 6-FDA Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe 6-FDA Sales Value (2021-2032)
  15. 6.7.2 Europe 6-FDA Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific 6-FDA Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific 6-FDA Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America 6-FDA Sales Value (2021-2032)
  21. 6.9.2 South America 6-FDA Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa 6-FDA Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa 6-FDA Sales Value Share by Country, 2025 VS 2032
7 6-FDA Country-level Sales and Value Analysis
  1. 7.1 Global 6-FDA Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global 6-FDA Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global 6-FDA Sales by Country (2021-2032)
  4. 7.3.1 Global 6-FDA Sales by Country (2021-2026)
  5. 7.3.2 Global 6-FDA Sales by Country (2027-2032)
  6. 7.4 Global 6-FDA Sales Value by Country (2021-2032)
  7. 7.4.1 Global 6-FDA Sales Value by Country (2021-2026)
  8. 7.4.2 Global 6-FDA Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA 6-FDA Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA 6-FDA Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA 6-FDA Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada 6-FDA Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada 6-FDA Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada 6-FDA Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico 6-FDA Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico 6-FDA Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico 6-FDA Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany 6-FDA Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany 6-FDA Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany 6-FDA Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France 6-FDA Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France 6-FDA Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France 6-FDA Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. 6-FDA Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. 6-FDA Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. 6-FDA Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy 6-FDA Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy 6-FDA Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy 6-FDA Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain 6-FDA Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain 6-FDA Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain 6-FDA Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia 6-FDA Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia 6-FDA Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia 6-FDA Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands 6-FDA Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands 6-FDA Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands 6-FDA Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries 6-FDA Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries 6-FDA Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries 6-FDA Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China 6-FDA Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China 6-FDA Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China 6-FDA Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan 6-FDA Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan 6-FDA Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan 6-FDA Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea 6-FDA Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea 6-FDA Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea 6-FDA Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India 6-FDA Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India 6-FDA Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India 6-FDA Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia 6-FDA Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia 6-FDA Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia 6-FDA Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia 6-FDA Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia 6-FDA Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia 6-FDA Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil 6-FDA Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil 6-FDA Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil 6-FDA Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina 6-FDA Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina 6-FDA Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina 6-FDA Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile 6-FDA Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile 6-FDA Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile 6-FDA Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia 6-FDA Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia 6-FDA Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia 6-FDA Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru 6-FDA Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru 6-FDA Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru 6-FDA Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia 6-FDA Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia 6-FDA Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia 6-FDA Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel 6-FDA Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel 6-FDA Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel 6-FDA Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE 6-FDA Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE 6-FDA Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE 6-FDA Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey 6-FDA Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey 6-FDA Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey 6-FDA Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran 6-FDA Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran 6-FDA Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran 6-FDA Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt 6-FDA Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt 6-FDA Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt 6-FDA Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Daikin
  2. 8.1.1 Daikin Company Information
  3. 8.1.2 Daikin Business Overview
  4. 8.1.3 Daikin 6-FDA Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Daikin 6-FDA Product Portfolio
  6. 8.1.5 Daikin Recent Developments
  7. 8.2 Chemours
  8. 8.2.1 Chemours Company Information
  9. 8.2.2 Chemours Business Overview
  10. 8.2.3 Chemours 6-FDA Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chemours 6-FDA Product Portfolio
  12. 8.2.5 Chemours Recent Developments
  13. 8.3 Chinatech Chemical
  14. 8.3.1 Chinatech Chemical Company Information
  15. 8.3.2 Chinatech Chemical Business Overview
  16. 8.3.3 Chinatech Chemical 6-FDA Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chinatech Chemical 6-FDA Product Portfolio
  18. 8.3.5 Chinatech Chemical Recent Developments
  19. 8.4 Zigong Zhongtiansheng New Material
  20. 8.4.1 Zigong Zhongtiansheng New Material Company Information
  21. 8.4.2 Zigong Zhongtiansheng New Material Business Overview
  22. 8.4.3 Zigong Zhongtiansheng New Material 6-FDA Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zigong Zhongtiansheng New Material 6-FDA Product Portfolio
  24. 8.4.5 Zigong Zhongtiansheng New Material Recent Developments
  25. 8.5 Zhejiang Nuocheng
  26. 8.5.1 Zhejiang Nuocheng Company Information
  27. 8.5.2 Zhejiang Nuocheng Business Overview
  28. 8.5.3 Zhejiang Nuocheng 6-FDA Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang Nuocheng 6-FDA Product Portfolio
  30. 8.5.5 Zhejiang Nuocheng Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 6-FDA Value Chain Analysis
  2. 9.1.1 6-FDA Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 6-FDA Sales Mode & Process
  6. 9.2 6-FDA Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 6-FDA Distributors
  9. 9.2.3 6-FDA Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst